BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND MDM4, DKFZp781B1423, 4194, ENSG00000198625, RP11-430C7_1, MRP1, MDMX, MGC132766 AND Treatment
12600 results:

  • 1. Development and validation of radiomics nomogram for metastatic status of epithelial ovarian cancer.
    Leng Y; Wang X; Zheng T; Peng F; Xiong L; Wang Y; Gong L
    Sci Rep; 2024 May; 14(1):12456. PubMed ID: 38816463
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epithelial ovarian cancer and brain metastases: might the
    Sassu CM; Marchetti C; Russo G; Minucci A; Boccia SM; Benato A; Nero C; Piermattei A; Mattogno PP; Giannarelli D; Ferrandina G; Olivi A; Fagotti A; Scambia G
    Int J Gynecol Cancer; 2024 Jan; 34(1):88-98. PubMed ID: 38805344
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Impact of Mitochondria in ovarian cancer Cell Metabolism, Proliferation, and Metastasis.
    Schatten H
    Adv Exp Med Biol; 2024; 1452():119-125. PubMed ID: 38805128
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tubulin Complexity in cancer and Metastasis.
    Danziger M; Xu F; Noble H; Yang P; Roque DM
    Adv Exp Med Biol; 2024; 1452():21-35. PubMed ID: 38805123
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Analysis of sequential chemotherapy efficacy in ovarian epithelial carcinoma, fallopian tube carcinoma and primary peritoneal carcinoma].
    Shen XY; Li XP; Wang Y; Wu Y; Li Y; Yang YC; Wei LH; Fan Y; Tang ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2024 May; 59(5):383-390. PubMed ID: 38797568
    [No Abstract]    [Full Text] [Related]  

  • 6. Transcriptome profiling and characterization of peritoneal metastasis ovarian cancer xenografts in humanized mice.
    Kang SW; Lee JY; Kang OJ; Kim YM; Choi EK; Lee SW
    Sci Rep; 2024 May; 14(1):11894. PubMed ID: 38789484
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Paeoniflorigenone inhibits ovarian cancer metastasis through targeting the MUC1/Wnt/β‑catenin pathway.
    Liu Q; Jiang L; Zhao Y; Su F; Li J; Tian X; Liu W; Jiang X; Xu Y; Tao F
    Int J Mol Med; 2024 Jul; 54(1):. PubMed ID: 38785138
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer.
    Erturk A; Korkmaz E; Arslantas Z; Bekdemir S; Erturk NK
    Rev Assoc Med Bras (1992); 2024; 70(5):e20231115. PubMed ID: 38775501
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Racial and Ethnic Inequities in cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.
    Islam JY; Hathaway CA; Hume E; Turner K; Hallanger-Johnson J; Tworoger SS; Camacho-Rivera M
    JAMA Netw Open; 2024 May; 7(5):e2412050. PubMed ID: 38767916
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC.
    Huang Z; Li L; Gong Z; Tang L
    Clin Appl Thromb Hemost; 2024; 30():10760296241255958. PubMed ID: 38767088
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
    Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
    JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes.
    Ullah A; Chen Y; Singla RK; Cao D; Shen B
    Pharmacol Res; 2024 Jun; 204():107213. PubMed ID: 38750677
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation.
    Wang M; Sun Y; Gu R; Tang Y; Han G; Zhao S
    J Ovarian Res; 2024 May; 17(1):101. PubMed ID: 38745186
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Perioperative management of a patient with unexpectedly detected early-stage ovarian mucinous carcinoma combined with progressive bulbar paralysis: a case report and literature review.
    Zhang D; Xu R; Huo T; Liu Y; Hao Z; Sun Y; Xi X; Du X; Wang L; Du J
    BMC Womens Health; 2024 May; 24(1):274. PubMed ID: 38704534
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial.
    Belotte J; Felicetti B; Baines AJ; YoussefAgha A; Rojas-Espaillat L; Ortiz AG; Provencher D; Vázquez RM; Cortijo LG; Zeng X
    Trials; 2024 May; 25(1):301. PubMed ID: 38702828
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of recurrent ovarian cancer: A systematic review and meta-analysis.
    Chen Y; Liu X; Hu Y; Xia L
    Medicine (Baltimore); 2024 May; 103(18):e38019. PubMed ID: 38701316
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.
    Nan Y; Wu X; Luo Q; Chang W; Zhao P; Zhang L; Liu Z
    Proc Natl Acad Sci U S A; 2024 May; 121(19):e2315348121. PubMed ID: 38701117
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of human dCTP pyrophosphatase 1 (DCTPP1) and its association with cisplatin resistance characteristics in ovarian cancer.
    Wang Y; Chen X; Chen Q; Liu T; Wu Y; Huang L; Chen Y
    J Cell Mol Med; 2024 May; 28(9):e18371. PubMed ID: 38686496
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Novel Non-Psychoactive Fatty Acid from a Marine Snail,
    Vijayaraghavan CS; Raman LS; Surenderan S; Kaur H; Chinambedu MD; Thyagarajan SP; Gnanambal Krishnan ME
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675558
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 630.